Mrs Sonya Sebren Summerlin, | |
17 Peachtree Ln, Madison, MS 39110-9217 | |
(601) 906-2375 | |
Not Available |
Full Name | Mrs Sonya Sebren Summerlin |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 17 Peachtree Ln, Madison, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144843772 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | T0177 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Sonya Sebren Summerlin, 17 Peachtree Ln, Madison, MS 39110-9217 Ph: (601) 906-2375 | Mrs Sonya Sebren Summerlin, 17 Peachtree Ln, Madison, MS 39110-9217 Ph: (601) 906-2375 |
News Archive
Sen. Charles Grassley, R-Iowa, remains on the fence about several provisions in a Democratic plan, The Washington Post reports: "Winning over the Senate Finance Committee's ranking Republican would represent a major coup for Democrats and a rare defection from the GOP party line for Grassley, a populist at heart but a loyal Republican according to his voting record.
A recent study conducted at the University of Malta Medical School, Malta, has revealed that a drop in the level of particulate matter 2.5 (PM2.5), which are airborne pollutant particles with a diameter of 2.5 micrometer, in the atmosphere due to lockdown is associated with the arrival of a newer variant of SARS-CoV-2, which has eventually displaced the original virus after lockdown.
QLT Inc. ("QLT" or the "Company") today announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne(R) patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.
Today, the U.S. Food and Drug Administration took new steps as part of its broader efforts to address the opioid crisis by approving the final Opioid Analgesic Risk Evaluation and Mitigation Strategy.
› Verified 3 days ago
Mr. Michael Preston, LPC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 940 Ebenezer Blvd, Madison, MS 39110 Phone: 321-480-5000 |